Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.22 -0.16 (-3.65%)
As of 04/29/2025 03:56 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.15 billion
P/E Ratio
30.14
Consensus Rating
Strong Buy
Volume
22,523 shares
Average Volume
104,738 shares
Today's Range
$4.22
$4.34
Stardust Power stock logo

2. Stardust Power NASDAQ:SDST

$0.50 +0.00 (+0.95%)
As of 03:45 PM Eastern

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$28.95 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+922.5% Upside)
Volume
182,770 shares
Average Volume
347,818 shares
Today's Range
$0.49
$0.51
OS Therapies stock logo

3. OS Therapies NYSE:OSTX

$1.98 -0.02 (-1.00%)
As of 03:43 PM Eastern

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$42.90 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+809.1% Upside)
Volume
319,545 shares
Average Volume
483,576 shares
Today's Range
$1.80
$2.10
Denison Mines stock logo

4. Denison Mines NYSEAMERICAN:DNN

$1.42 0.00 (-0.01%)
As of 03:47 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.27 billion
P/E Ratio
-141.99
Consensus Rating
Buy
Consensus Price Target
$3.00 (+111.3% Upside)
Volume
54.79 million shares
Average Volume
30.25 million shares
OnKure Therapeutics stock logo

5. OnKure Therapeutics NASDAQ:OKUR

$2.48 -0.05 (-1.98%)
As of 03:45 PM Eastern

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$33.32 million
P/E Ratio
-0.20
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,203.8% Upside)
Volume
30,657 shares
Average Volume
82,057 shares
Bioceres Crop Solutions stock logo

6. Bioceres Crop Solutions NASDAQ:BIOX

$4.19 -0.08 (-1.87%)
As of 03:41 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$262.76 million
P/E Ratio
209.60
Consensus Rating
Buy
Consensus Price Target
$8.63 (+105.8% Upside)
Volume
38,517 shares
Average Volume
167,786 shares
Solid Biosciences stock logo

7. Solid Biosciences NASDAQ:SLDB

$3.30 +0.25 (+8.20%)
As of 03:40 PM Eastern

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$255.73 million
P/E Ratio
-1.09
Consensus Rating
Buy
Consensus Price Target
$15.67 (+374.7% Upside)
Volume
711,040 shares
Average Volume
938,193 shares
Cardiol Therapeutics stock logo

8. Cardiol Therapeutics NASDAQ:CRDL

$1.11 -0.04 (-3.83%)
As of 03:46 PM Eastern

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$91.37 million
P/E Ratio
-2.84
Consensus Rating
Buy
Consensus Price Target
$8.40 (+659.5% Upside)
Volume
151,910 shares
Average Volume
382,081 shares
GeoVax Labs stock logo

9. GeoVax Labs NASDAQ:GOVX

$0.99 -0.01 (-0.76%)
As of 03:45 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$13.72 million
P/E Ratio
-0.17
Consensus Rating
Buy
Consensus Price Target
$12.90 (+1,200.8% Upside)
Volume
211,507 shares
Average Volume
590,120 shares
Quince Therapeutics stock logo

10. Quince Therapeutics NASDAQ:QNCX

$1.07 -0.06 (-5.31%)
As of 03:23 PM Eastern

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$47.21 million
P/E Ratio
-0.86
Consensus Rating
Buy
Consensus Price Target
$8.00 (+647.7% Upside)
Volume
74,904 shares
Average Volume
248,166 shares
Reviva Pharmaceuticals stock logo

11. Reviva Pharmaceuticals NASDAQ:RVPH

$0.87 -0.01 (-1.28%)
As of 03:38 PM Eastern

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$40.47 million
P/E Ratio
-0.78
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,055.0% Upside)
Volume
221,214 shares
Average Volume
1.13 million shares
Immunic stock logo

12. Immunic NASDAQ:IMUX

$0.99 -0.29 (-22.75%)
As of 03:46 PM Eastern

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$94.75 million
P/E Ratio
-0.80
Consensus Rating
Buy
Consensus Price Target
$13.20 (+1,235.0% Upside)
Volume
8.21 million shares
Average Volume
672,924 shares
Mereo BioPharma Group stock logo

13. Mereo BioPharma Group NASDAQ:MREO

$2.58 +0.06 (+2.38%)
As of 03:40 PM Eastern

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$410.22 million
P/E Ratio
-43.00
Consensus Rating
Buy
Consensus Price Target
$7.71 (+199.0% Upside)
Volume
662,176 shares
Average Volume
1.10 million shares
Lavoro stock logo

14. Lavoro NASDAQ:LVRO

$2.71 -0.21 (-7.19%)
As of 03:37 PM Eastern

Lavoro Limited operates as an agricultural inputs retailer. The company operates through three segments: Brazil Cluster, LATAM Cluster, and Crop Care Cluster. More about Lavoro

Market Capitalization
$316.01 million
P/E Ratio
-1.66
Consensus Rating
Buy
Consensus Price Target
$5.13 (+89.1% Upside)
Volume
4,218 shares
Average Volume
7,764 shares
Nkarta stock logo

15. Nkarta NASDAQ:NKTX

$2.12 +0.17 (+8.72%)
As of 03:40 PM Eastern

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$150.43 million
P/E Ratio
-1.13
Consensus Rating
Buy
Consensus Price Target
$14.86 (+600.8% Upside)
Volume
381,650 shares
Average Volume
1.09 million shares
Rezolve AI stock logo

16. Rezolve AI NASDAQ:RZLV

$2.26 -0.17 (-7.00%)
As of 03:40 PM Eastern

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$389.13 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+165.5% Upside)
Volume
5.04 million shares
Average Volume
5.24 million shares
Today's Range
$2.17
$2.33
Full House Resorts stock logo

17. Full House Resorts NASDAQ:FLL

$3.23 -0.05 (-1.52%)
As of 03:46 PM Eastern

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$116.20 million
P/E Ratio
-2.74
Consensus Rating
Buy
Consensus Price Target
$6.33 (+96.1% Upside)
Volume
68,250 shares
Average Volume
134,767 shares
Alumis stock logo

18. Alumis NASDAQ:ALMS

$4.22 -0.11 (-2.54%)
As of 03:45 PM Eastern

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$199.28 million
Consensus Rating
Buy
Consensus Price Target
$25.86 (+512.7% Upside)
Volume
138,899 shares
Average Volume
315,834 shares
Today's Range
$4.08
$4.48
United States Antimony stock logo

19. United States Antimony NYSE:UAMY

$3.21 -0.08 (-2.43%)
As of 03:47 PM Eastern

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$367.97 million
P/E Ratio
-80.25
Consensus Rating
Buy
Consensus Price Target
$2.90 (-9.7% Downside)
Volume
2.19 million shares
Average Volume
2.02 million shares
Ur-Energy stock logo

20. Ur-Energy NYSEAMERICAN:URG

$0.76 +0.01 (+0.70%)
As of 03:47 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur-Energy

Market Capitalization
$276.53 million
P/E Ratio
-5.84
Consensus Rating
Buy
Consensus Price Target
$2.30 (+202.8% Upside)
Volume
1.93 million shares
Average Volume
4.17 million shares
Western Copper & Gold stock logo

21. Western Copper & Gold NYSE:WRN

$1.11 +0.00 (+0.44%)
As of 03:41 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$221.98 million
P/E Ratio
-55.50
Consensus Rating
Buy
Consensus Price Target
$4.25 (+282.9% Upside)
Volume
244,765 shares
Average Volume
333,012 shares
Cingulate stock logo

22. Cingulate NASDAQ:CING

$4.23 +0.05 (+1.20%)
As of 03:38 PM Eastern

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. More about Cingulate

Market Capitalization
$16.67 million
P/E Ratio
-0.29
Consensus Rating
Buy
Consensus Price Target
$30.67 (+625.0% Upside)
Volume
111,389 shares
Average Volume
1.07 million shares
Orchestra BioMed stock logo

23. Orchestra BioMed NASDAQ:OBIO

$2.94 +0.41 (+16.21%)
As of 03:46 PM Eastern

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$112.64 million
P/E Ratio
-1.83
Consensus Rating
Buy
Consensus Price Target
$15.00 (+410.2% Upside)
Volume
628,043 shares
Average Volume
152,371 shares
Contineum Therapeutics stock logo

24. Contineum Therapeutics NASDAQ:CTNM

$4.15 -0.26 (-5.90%)
As of 03:42 PM Eastern

Contineum Therapeutics, Inc, a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. More about Contineum Therapeutics

Market Capitalization
$107.37 million
P/E Ratio
-0.85
Consensus Rating
Buy
Consensus Price Target
$23.75 (+472.3% Upside)
Volume
20,636 shares
Average Volume
78,860 shares
HIVE Digital Technologies stock logo

25. HIVE Digital Technologies NASDAQ:HIVE

$1.68 -0.05 (-2.62%)
As of 03:38 PM Eastern

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$285.45 million
P/E Ratio
-33.50
Consensus Rating
Buy
Consensus Price Target
$7.64 (+356.3% Upside)
Volume
7.05 million shares
Average Volume
6.23 million shares